Company overview

We are Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first clinical development programme is researching investigational COMP360 psilocybin treatment for patients with treatment-resistant depression. We want to transform the patient experience in mental health care.
Founded in 2016
London, England, GBR
227 employees (6 in marketing)
92% recommend to a friend
92% positive business outlook

Salaries

Typical salary range

$190,000 – $240,000

/ yr

Help build salary transparency at Compass Pathways

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

9 open now

Headcount trend

Company growth over the last 12 months

Headcount -1.3% year over year

Funding

Total funding

$771.2M

Last raise

$200M

Post IPO Equity, 18 days ago

Funding history

Feb 2026

Post IPO Equity COMPASS Pathways · $200M

Feb 2026

Post IPO Equity COMPASS Pathways · $150M

Jan 2025

Post IPO Equity COMPASS Pathways · $150M

Aug 2023

Post IPO Equity COMPASS Pathways · $125M

Jul 2023

Post IPO Debt COMPASS Pathways · $30M

Apr 2020

Series B COMPASS Pathways · $80M

Audience

Monthly website visitors
28.4K
Month over month+22.5%
Quarter over quarter-14.9%
Top sourceSearch (48.7%)
Ad budget per month$0.0
Average search rank43.5
Traffic source mix
Search
48.7%
Direct
38.3%
Referral
9.2%
Social
2.6%
Paid referral
1.1%

LinkedIn followers

Follower count and growth

Total followers

39.6K

12-mo growth

+16.2%

Monthly growth

+3.9%

News

Links